Biocon Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Press Release titled Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara?, in Europe, UK, Canada, and Japan ".
Biocon Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Press Release titled Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara?, in Europe, UK, Canada, and Japan ".